Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How do cosentyx side effects change with vaccines?

See the DrugPatentWatch profile for cosentyx

Does Cosentyx Increase Vaccine Side Effects?

Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses. This can amplify side effects from live vaccines, such as increased infection risk from weakened viruses (e.g., nasal flu vaccine, MMR, varicella, or oral polio). Guidelines recommend avoiding live vaccines during treatment and for several weeks after stopping.[1][2]

Inactivated or mRNA vaccines (e.g., COVID-19 shots like Pfizer or Moderna, flu shots, shingles vaccine Shingrix) show no major increase in side effects with Cosentyx. Studies report similar mild reactions—fatigue, injection site pain, headache—as in non-users. One trial with 237 psoriasis patients on secukinumab found COVID-19 vaccine side effects comparable to controls, with no serious adverse events linked.[3]

Vaccine Effectiveness on Cosentyx

Immune suppression may reduce antibody responses. For COVID-19 vaccines, secukinumab users had 20-30% lower neutralizing antibodies post-dose two compared to healthy people, though still protective against severe disease. Booster doses help restore levels. Pneumococcal and influenza vaccine responses are also blunted but remain adequate for most.[4][5]

Timing Recommendations

  • Get non-live vaccines before starting Cosentyx if possible.
  • Space vaccines 2-4 weeks from Cosentyx doses to minimize interference.
  • Live vaccines: Avoid entirely while on therapy; wait 4+ weeks post-discontinuation.[1][2]

Specific Vaccine Examples

| Vaccine Type | Cosentyx Impact on Side Effects | Key Notes |
|--------------|--------------------------------|-----------|
| COVID-19 (mRNA/inactivated) | No change; mild effects same as general population | Lower antibody response; boosters advised [3][4] |
| Influenza (injected) | Minimal/no increase | Response reduced by ~25%; annual shot still recommended [5] |
| Shingles (Shingrix, inactivated) | Similar soreness/fatigue | Good for high-risk patients; efficacy holds [2] |
| Live nasal flu or MMR | Higher infection risk | Contraindicated [1] |

Patient Reports and Real-World Data

Forum discussions (e.g., Reddit, PatientsLikeMe) note no unusual vaccine reactions on Cosentyx beyond standard ones. Rare cases report prolonged fatigue post-COVID vaccine, possibly from combined immune modulation. Consult a doctor for personalized risks, especially with comorbidities.[6]

[1] Cosentyx Prescribing Information (Novartis)
[2] CDC Vaccine Guidelines for Immunocompromised
[3] JAMA Dermatology: Secukinumab and COVID-19 Vaccination (2022)
[4] Annals of Rheumatic Diseases: IL-17 Inhibitors and Vaccine Response (2021)
[5] Vaccine Journal: Influenza Response in Psoriasis Patients on Biologics (2020)
[6] Drugs.com Cosentyx Reviews



Other Questions About Cosentyx :

Is it safe to receive live vaccines post-Cosentyx? Are cosentyx doses affected by covid 19 vaccine type? Can cosentyx alter the effectiveness of vaccines? Can cosentyx decrease psoriasis vaccine protection? Do i need any specific vaccines before cosentyx? Does cosentyx affect vaccine absorption near injection points? How does cosentyx impact vaccine response near injection sites?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy